Nyxoah SA EBITDA Margin 2021-2024 | NYXH
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Nyxoah SA (NYXH) over the last 10 years. The current EBITDA margin for Nyxoah SA as of September 30, 2024 is .
| Nyxoah SA EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $0.01B | $-0.05B | -1080.00% |
| 2024-06-30 | $0.01B | $-0.05B | -980.00% |
| 2024-03-31 | $0.01B | $-0.05B | -940.00% |
| 2023-12-31 | $0.00B | $-0.05B | -1150.00% |
| 2023-09-30 | $0.00B | $-0.04B | -1466.67% |
| 2023-06-30 | $0.00B | $-0.04B | -2050.00% |
| 2023-03-31 | $0.00B | $-0.04B | -1800.00% |
| 2022-12-31 | $0.00B | $-0.03B | -1066.67% |
| 2022-06-30 | $0.00B | $-0.02B | -1050.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.352B | $0.005B |
| Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium. | |||